SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-13-210982
Filing Date
2013-05-09
Accepted
2013-05-09 16:06:16
Documents
11
Period of Report
2013-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q d515000d10q.htm 10-Q 252889
2 EX-10.1 d515000dex101.htm EX-10.1 18906
3 EX-31.1 d515000dex311.htm EX-31.1 6764
4 EX-31.2 d515000dex312.htm EX-31.2 6764
5 EX-32.1 d515000dex321.htm EX-32.1 5199
  Complete submission text file 0001193125-13-210982.txt   1777648

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT oxgn-20130331.xml EX-101.INS 164585
7 XBRL TAXONOMY EXTENSION SCHEMA oxgn-20130331.xsd EX-101.SCH 20501
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE oxgn-20130331_cal.xml EX-101.CAL 24716
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE oxgn-20130331_def.xml EX-101.DEF 45822
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE oxgn-20130331_lab.xml EX-101.LAB 171750
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE oxgn-20130331_pre.xml EX-101.PRE 115040
Mailing Address 701 GATEWAY BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address 701 GATEWAY BLVD. SOUTH SAN FRANCISCO CA 94080 650-635-7000
OXIGENE INC (Filer) CIK: 0000908259 (see all company filings)

IRS No.: 133679168 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-21990 | Film No.: 13828678
SIC: 2836 Biological Products, (No Diagnostic Substances)